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Abstract
Perceptions that stress causes and stress-reduction controls hypertension have been associated with
poorer blood pressure control in hypertension populations. The current study investigated these
“stress-model perceptions” in stroke survivors regarding prevention of recurrent stroke and the
influence of these perceptions on patients’ stroke risk-factor control. Stroke and transient ischemic
attack survivors (N=600) participated in an in-person interview in which they were asked about
their beliefs regarding control of future stroke; blood pressure and cholesterol were measured
directly after the interview. Counter to expectations, patients who endorsed a “stress-model” but
not a “medication-model” of stroke prevention were in better control of their stroke risk-factors
(blood pressure and cholesterol) than those who endorsed a medication-model but not a stress-
model of stroke prevention (OR for poor control=.54, Wald statistic=6.07, p=.01). This result was
not explained by between group differences in patients’ reported medication adherence. The
results have implications for theory and practice, regarding the role of stress-belief models and
acute cardiac events, compared to chronic hypertension.
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Blood pressure (BP) and cholesterol control are essential for preventing recurrent stroke
among stroke and transient ischemic attack (TIA) survivors (Lakhan & Sapko, 2009). Very
little is known about the psychological factors of survivors for predicting their adherence to
stroke-prevention medications and their hard outcomes (BP/cholesterol levels).
More is known regarding these factors in hypertensive patients. Despite hypertension being
essentially asymptomatic, hypertensive patients who believe their medications control their
hypertension-related symptoms are more adherent (Meyer et al., 1985), and their treatment-
control beliefs positively predict BP control (Ross et al., 2004). Researchers have identified
common clusters of patient beliefs (belief models) that are important for predicting
hypertension-treatment adherence and outcomes (Heckler et al., 2008; Kleinman, 1980).
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Specifically, patients who endorse a stress model of hypertension perceive their condition to
be caused by stress and controlled through stress-reduction; patients who endorse a medical/
medication model of hypertension perceive their condition to be caused by biological and/or
lifestyle factors and controlled through medication (Leventhal et al., 2008). Although there
may be some overlap in patients who endorse these models, stress model endorsement in
hypertension patients (particularly African-Americans) has been associated with poorer
adherence and BP control, compared to medication/medical-model endorsement (Heckler et
al., 2008; Heurtin-Roberts & Reisin, 1990).
The current study assesses the prevalence of stress-model endorsement of stroke prevention
(versus medication-model endorsement) and its relationship to patients’ medication
adherence and stroke risk-factor control (BP/cholesterol) in a low-income, urban, largely
African American population of stroke/TIA survivors. Unlike hypertension, strokes are
symptomatic, and those who have experienced a stroke/TIA may have different models of
illness that, if uncovered, could lead to improvements in the key factor that leads to
recurrence—blood pressure control.
If we find that stress-model endorsement for stroke prevention influences adherence to
medications and/or risk factor control, then interventions to address such beliefs may be
warranted (Broadbent et al., 2009). Further, this research may have implications for
survivors of other acute events, such as heart attacks. Affleck and colleagues (1987) found
that stress-causal beliefs predicted 8-year morbidity post-heart attack, but the effect of
‘stress models’ of acute events has yet to be investigated.
We test two a priori hypotheses:
Hypothesis 1 Stress-model and medication-model endorsement will not be mutually
exclusive; some individuals will endorse stress-reduction, some will
endorse medication, and some will endorse both for preventing stroke.
Hypothesis 2 Stress-model endorsement in conjunction with not endorsing a
medication-model will be most detrimental for medication adherence
and future-stroke risk factor control.
Methods
Participants and Procedure
Volunteers (n=600) from low income, Black and Latino communities participated in a
stroke-prevention intervention (inclusion criteria: ≥40 years, ≥1 stroke/TIA in the past 5
years, no significant cognitive impairment, English or Spanish speaker). Research staff
recruited in person from community and medical centers (+response rate=47%), obtained
informed consent, and collected the measures listed below in a baseline interview, with
approval from the supporting institution’s ethics committee.
Measures
Stress- and medication-model endorsement—Patients were asked, “If you were
going to advise someone, what are the 3 most important things you would recommend they
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do to lower their risk of having a stroke?” Responses were coded as “recommending stress
reduction/avoiding stressful situations” and “recommending medications” (BP, cholesterol,
antithrombotic/blood thinner), among other codes not relevant to this analysis
(“recommending control of diabetes”). These codes were developed from previous literature
(Reeves, Hogan, & Rafferty, 2002) and pilot tested with a stroke-survivor focus group
before administration to the current sample. Patients were categorized as “medication-only
endorsers” if they recommended medication adherence but not stress reduction; as “stress-
model-only endorsers” if they recommended stress reduction but not medication adherence;
or as recommending “both” or “neither”.
Risk-factor control—This was calculated as a dichotomous variable (0=poor control;
1=good control), based on patients’ BP/cholesterol levels at baseline. Patients’ BP was
measured three times and averaged. Direct LDL cholesterol was measured via blood
samples. Poor control was defined as systolic BP level ≥ 140/90mmHg and/or LDL ≥
100mg/dl.
Medication adherence—This was measured using the Morisky Medication Adherence
Scale (MMAS; Morisky et al., 2008), an 8-item self-report measure with 7 yes/no items
(e.g., “Did you take your medicine(s) yesterday?”) and one 5-option item (“How often do
you have difficulty remembering to take all your medicines?”). Conventional scoring was
used but reversed so that higher scores represented greater/better adherence.
Analysis Overview—The proportion of the total sample in each of the designated groups
was calculated to test Hypothesis 1. Hierarchical, categorical logistic regression was used to
test Hypothesis 2. ANOVA was used to compare mean adherence rates between the groups.
Results
As shown in Table 1, the sample was characteristic of the target population, with
approximately 80% being Black or Latino and 60% earning less than $15,000 per year.
There were no significant differences in any of the variables or relationships of interest
between TIA-only survivors (n=284) and stroke-survivors (n=316); therefore, all analyses
were conducted with the full dataset.
Hypothesis 1
The data support the hypothesis: there were patients in each of the four endorsement groups;
20% endorsed medications but not stress-reduction for stroke prevention, 27% endorsed
stress-reduction but not medications for stroke prevention; 44% endorsed both; and 9%
endorsed neither.
Hypothesis 2
Surprisingly, the hypothesis was not only rejected, but stress-only endorsers were in
statistically better control of their risk factors (OR for poor control=0.54, Wald
statistic=6.07, p=.01). This did not appear to be due to differences in adherence to
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medications; no significant difference existed between groups in their self-reported
adherence (F(3, 588)=1.54, p=0.20).
Sixty-three percent of the patients who endorsed both models were in poor control (n.s.
different from the medication-only endorsers); 57% of patients who endorsed neither model
were in poor control (OR for poor control compared to mediation-only endorsers=0.63,
Wald statistic=3.97, p<0.05).
Discussion
This study was designed to assess stroke/TIA survivors’ stress-model beliefs regarding
prevention of recurrent stroke and their relationship to risk-factor control. A substantial
percentage of survivors endorsed both stress-model-only and medication-only models for
prevention of recurrent stroke, indicating that they are not mutually exclusive groups, or
neither, suggesting that future research should evaluate beliefs that are neither stress-related
nor medical in nature and their influence on patients’ behaviors and outcomes.
Counter to our second hypothesis, we found that stress-model-only endorsers had better
control of their stroke risk factors—BP and cholesterol—than the medication-model-only
endorsers. This finding is not explained by differences in self-reported medication adherence
between the two groups. Several possible explanations exist: first, those who endorse a
medication-only model may be those who deny the importance of life-style factors in the
onset of stroke and may therefore be less healthy in their lifestyles overall. Second, patients’
beliefs regarding the effect of stress on stroke avoidance might change with the experience
of a stroke. This is the first research to investigate the effect of stress-model endorsement for
preventing acute events, such as heart attack or stroke; researchers have yet to theorize what
the effect on stress-related causal and control beliefs might be after experiencing an acute
event. Our hypothesis regarding poorer control of stroke risk factors with stress-model
endorsement may only be relevant to individuals before they experience their first stroke.
We tested a third possibility—that race or ethnic differences in those who endorsed a stress-
only model may have accounted for the differences in risk factor control. Although a larger
proportion of Latinos endorsed a stress-only model than did Whites or Blacks, Latinos were
no different in their level of BP/LDL control than the other ethnic groups.
Patients who endorsed both models were in no better control of their risk factors than were
those who endorsed medications-only. Medication endorsement, regardless of stress-model
endorsement, may result in poorer risk factor control; conversely, poorer risk factor control
may make individuals more likely to endorse medication. Research should investigate the
causal influences, if any, of each factor on the other. Patients who endorsed neither model
were in slightly better control than the medication-only group; research should identify the
nature of these patients’ belief models in order to evaluate the potential causes of this
difference.
A limitation of the current study was the fact that the response codes used by interviewers to
record patients’ responses to the item regarding the top three things they would recommend
to prevent stroke were not easily parsed into mutually exclusive categories needed for
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testing the hypothesis. If a patient gave a vague response (e.g., ‘control blood pressure’), it
was not clear to the interviewer whether the patient meant through stress reduction, by
taking medication, or through some other behavior. To better assess the hypotheses, future
research can utilize this simple measure but improve upon the coded response options
through training interviewers to follow-up with questions for specificity.
These findings call into question the generalizability of the findings among hypertensive
patients that link stress-model endorsement to poorer medication adherence and BP control.
Addressing stress-model beliefs in clinical practice or via interventions for acute events may
not be advisable. More research is warranted to determine the effects of these belief-models
before interventions are suggested for patients or providers.
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Table 1
Demographic information and descriptive statistics of study variables for the full sample.
Variable/Characteristic Possible or Observed
Range
Mean (SD) or Percentage
Sample size 600
Age 40–90 years 63.40(11.22)
Female Gender 59%
Black Race, Non-Hispanic 47%
White Race, Non-Hispanic 15%
Hispanic Ethnicity 38%
Number of Stroke/TIA Events 1–14 1.68(1.28)
Years since last Stroke/TIA 0–5 years 1.81(1.45)
‘Poor Control’ of BP/cholesterol 0–100%
 Stress-model-only 53%
 Medication-model-only 68%
Medication Adherence (Morisky scale; higher values scored to indicate better
adherence)
0–8 6.06(1.71)
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